SC
ABBV icon

Slow Capital’s AbbVie ABBV Stock Holding History

Slow Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,575
Closed -$349K – 144
2021
Q4 		$349K Buy
2,575
+2
+0.1% +$236 0.06% 149
2021
Q3 		$278K Sell
2,573
-49
-2% -$5.6K 0.05% 164
2021
Q2 		$295K Buy
2,622
+39
+2% +$4.39K 0.06% 152
2021
Q1 		$279K Buy
2,583
+158
+7% +$16.9K 0.06% 158
2020
Q4 		$260K Buy
2,425
+416
+21% +$40K 0.06% 158
2020
Q3 		$176K Sell
2,009
-501
-20% -$47.2K 0.05% 172
2020
Q2 		$246K Sell
2,510
-219
-8% -$19.3K 0.07% 152
2020
Q1 		$208K Buy
2,729
+331
+14% +$28.2K 0.08% 156
2019
Q4 		$212K Buy
+2,398
New +$199K 0.07% 188

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Slow Capital's ABBV Position: Q1 2022 in Review

Slow Capital sold out of AbbVie (ABBV) in Q1 2022, closing a stake of 2,575 shares — an estimated $349K sold.

Slow Capital first reported a position in ABBV in Q4 2019 and held it in 9 quarters. The position peaked at $349K in Q4 2021. 3,052 funds tracked by Wall St. Rank hold ABBV as of Q1 2022.

  • Slow Capital reported no remaining AbbVie position as of Q1 2022 after selling out during the quarter.
  • Slow Capital sold 2,575 AbbVie shares in Q1 2022, an estimated $349K.
  • Slow Capital first reported a position in AbbVie in Q4 2019 and held it in 9 quarters.
  • Slow Capital's AbbVie position peaked at $349K in Q4 2021.
  • 3,052 funds tracked by Wall St. Rank held AbbVie as of Q1 2022.

Based on Slow Capital's 13F filing for Q1 2022, filed 2 May 2022.